drugset / Trial / NCT00633022
A Study to Evaluate the Effects of 3 Months Dosing With GW856553, as Assessed FDG-PET/CT Imaging
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is being conducted to assess the potential anti-inflammatory effects of a 3-month treatment with GW856553, on the inflammatory activity within the aorta and carotid plaques, as assessed by FDG-PET/CT.
Timeline
- Start
- 2008-06-02
- Primary completion
- 2009-12-03
- Completion
- 2009-12-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Losmapimod | Small molecule | 7.5 mg | Oral |